| HMDB0241873 | (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]cyclopentyl]hept-5-enoylcarnitine |  | C27H45NO7
495.657 495.319602793 | |
| HMDB0301620 | (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]-3-oxocyclopentyl]hept-5-enoyl-CoA |  | C41H64N7O20P3S
1099.97 1099.313969657 | |
| HMDB0241876 | (5Z)-7-[(1R,2R,5S)-5-Hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]-3-oxocyclopentyl]hept-5-enoylcarnitine |  | C27H43NO7
493.641 493.303952729 | |
| HMDB0301630 | (5Z)-7-[(1S,5E)-5-[(2E)-oct-2-en-1-ylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl-CoA |  | C41H62N7O18P3S
1065.96 1065.308490352 | |
| HMDB0241886 | (5Z)-7-[(1S,5E)-5-[(2E)-Oct-2-en-1-ylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoylcarnitine |  | C27H41NO5
459.627 459.298473424 | |
| HMDB0301648 | (5Z)-7-{2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoyl-CoA |  | C43H62F2N7O20P3S
1159.98 1159.295125918 | |
| HMDB0301622 | (5Z)-7-{2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-1-en-1-yl}hept-5-enoyl-CoA |  | C41H64N7O19P3S
1083.97 1083.319055037 | |
| HMDB0241878 | (5Z)-7-{2-[(1E,3R)-3-Hydroxyoct-1-en-1-yl]-5-oxocyclopent-1-en-1-yl}hept-5-enoylcarnitine |  | C27H43NO6
477.642 477.309038109 | |
| HMDB0340860 | (5Z)-pentadec-5-enoic acid |  | C15H28O2
240.387 240.208930142 | |
| HMDB0301227 | (5Z)-Pentadec-5-enoyl-CoA |  | C36H62N7O17P3S
989.91 989.313575732 | |
| HMDB0241441 | (5Z)-Pentadec-5-enoylcarnitine |  | C22H41NO4
383.573 383.303558804 | |
| HMDB0340938 | (5Z,14Z,17Z)-henicosa-5,14,17-trienoic acid |  | C21H36O2
320.517 320.271530399 | |
| HMDB0301372 | (5Z,14Z,17Z)-Henicosa-5,14,17-trienoyl-CoA |  | C42H70N7O17P3S
1070.04 1069.37617599 | |
| HMDB0241599 | (5Z,14Z,17Z)-Henicosa-5,14,17-trienoylcarnitine |  | C28H49NO4
463.703 463.366159062 | |
| HMDB0340561 | (5Z,7E)-3-hydroxydeca-5,7-dienoic acid |  | C10H16O3
184.235 184.109944375 | |
| HMDB0300910 | (5Z,7E)-3-Hydroxydeca-5,7-dienoyl-CoA |  | C31H50N7O18P3S
933.75 933.214589966 | |
| HMDB0241113 | (5Z,7E)-3-Hydroxydeca-5,7-dienoylcarnitine |  | C17H29NO5
327.421 327.204573038 | |
| HMDB0245858 | (5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene |  | C27H44
368.649 368.344301417 | |
| HMDB0301384 | (5Z,7S,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl-CoA |  | C43H66N7O19P3S
1110.01 1109.334705101 | |
| HMDB0241613 | (5Z,7S,8E,10Z,13Z,15E,17S,19Z)-7,17-Dihydroxydocosa-5,8,10,13,15,19-hexaenoylcarnitine |  | C29H45NO6
503.68 503.324688173 | |
| HMDB0301393 | (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoyl-CoA |  | C43H66N7O18P3S
1094.01 1093.339790481 | |
| HMDB0241622 | (5Z,7Z,10Z,13Z,16Z,19Z)-4-Hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine |  | C29H45NO5
487.681 487.329773553 | |
| HMDB0301363 | (5Z,8S,9E,11Z,14Z)-8-hydroxyicosa-5,9,11,14-tetraenoyl-CoA |  | C41H66N7O18P3S
1069.99 1069.339790481 | |
| HMDB0241590 | (5Z,8S,9E,11Z,14Z)-8-Hydroxyicosa-5,9,11,14-tetraenoylcarnitine |  | C27H45NO5
463.659 463.329773553 | |
| HMDB0041082 145297-96-7 | (5Z,8Z)-1,5,8-Heptadecatriene |  | C17H30
234.4201 234.23475096 | |